Download PDF
Thromb Haemost 2007; 97(03): 451-457
DOI: 10.1160/TH06-11-0646
Cardiovascular Biology and Cell Signalling
Schattauer GmbH

The –11377 C>G promoter variant of the adiponectin gene, prevalence of coronary atherosclerosis, and incidence of vascular events in men

Guenter Hoefle   *
1   Department of Medicine, Academic Teaching Hospital Feldkirch, Feldkirch, Austria
,
Axel Muendlein   *
2   Vorarlberg Institute for Vascular Investigation and Treatment, Academic Teaching Hospital Feldkirch, Feldkirch, Austria
3   University of Human Sciences, Triesen, Principality of Liechtenstein
,
Christoph H. Saely
1   Department of Medicine, Academic Teaching Hospital Feldkirch, Feldkirch, Austria
2   Vorarlberg Institute for Vascular Investigation and Treatment, Academic Teaching Hospital Feldkirch, Feldkirch, Austria
,
Lorenz Risch
1   Department of Medicine, Academic Teaching Hospital Feldkirch, Feldkirch, Austria
,
Philipp Rein
1   Department of Medicine, Academic Teaching Hospital Feldkirch, Feldkirch, Austria
2   Vorarlberg Institute for Vascular Investigation and Treatment, Academic Teaching Hospital Feldkirch, Feldkirch, Austria
,
Lorena Koch
2   Vorarlberg Institute for Vascular Investigation and Treatment, Academic Teaching Hospital Feldkirch, Feldkirch, Austria
,
Fabian Schmid
2   Vorarlberg Institute for Vascular Investigation and Treatment, Academic Teaching Hospital Feldkirch, Feldkirch, Austria
,
Stefan Aczel
1   Department of Medicine, Academic Teaching Hospital Feldkirch, Feldkirch, Austria
2   Vorarlberg Institute for Vascular Investigation and Treatment, Academic Teaching Hospital Feldkirch, Feldkirch, Austria
,
Thomas Marte
1   Department of Medicine, Academic Teaching Hospital Feldkirch, Feldkirch, Austria
2   Vorarlberg Institute for Vascular Investigation and Treatment, Academic Teaching Hospital Feldkirch, Feldkirch, Austria
,
Peter Langer
2   Vorarlberg Institute for Vascular Investigation and Treatment, Academic Teaching Hospital Feldkirch, Feldkirch, Austria
,
Heinz Drexel
1   Department of Medicine, Academic Teaching Hospital Feldkirch, Feldkirch, Austria
2   Vorarlberg Institute for Vascular Investigation and Treatment, Academic Teaching Hospital Feldkirch, Feldkirch, Austria
3   University of Human Sciences, Triesen, Principality of Liechtenstein
› Author AffiliationsFinancial support: We received research grants and financial support from: Dr. Egmond Frommelt and the Liechtenstein Global Trust (LGT) Bank Dkfm. Dr. Jodok Simma from the Hypo Bank Vorarlberg, Dr. Guntram Feuerstein and the Fachhochschule Dornbirn and the city of Dornbirn as well as Manfred Rein and Dr. Karlheinz Rüdisser from the Vorarlberger Landesregierung, Franz Rauch and the Vorarlberger Industriellenvereinigung, Dr. Peter Woess and the Vorarlberger Aerztekammer, and Luis Patsch, Director, Vorarlberger Krankenhaus-Betriebsgesellschaft.
Further Information

Publication History

Received 14 November 2006

Accepted after revision 22 February 2006

Publication Date:
15 December 2017 (online)

    Permissions and Reprints

Summary

No prospective data demonstrating an association between the –11377 C>G adiponectin gene promoter variant and cardiovascular risk are available. We therefore prospectively evaluated the cardiovascular risk associated with adiponectin gene single nucleotide polmorphisms (SNPs) including SNP –11377 in a consecutive series of men undergoing coronary angiography. We recorded vascular events over four years in 402 men undergoing coronary angiography for the evaluation of coronary artery disease. No significant associations of SNPs +276 G>T and +45 T>G with serum adiponectin, with significant coronary stenoses >50%, or with vascular events were observed. However, for SNP –11377 C>G, serum adiponectin levels significantly decreased (Ptrend = 0.003), and the prevalence of significant coronary stenoses significantly increased from the CC over the GC to the GG genotype (ptrend = 0.004). Prospectively, the risk of vascular events significantly increased from the CC over the CG to the GG genotype of this SNP (adjusted hazard ratios 1.555 [0.957-2.525] and 2.309 [1.067–4.998], respectively; ptrend = 0.014). The –11377 C>G adiponectin gene promoter variant is i) associated with decreased serum adiponectin levels, ii) correlated with the presence of coronary atherosclerosis and iii) significantly predictive of vascular events among men undergoing coronary angiography.

Keywords

Coronary artery disease - angiography - risk factors - cytokines - epidemiology

* Guenter Hoefle and Axel Muendlein contributed equally to this work.


 

  • References

  • 1 Despres JP. Intra-abdominal obesity: an untreated risk factor for Type 2 diabetes and cardiovascular disease. J Endocrinol Invest 2006; 29 (Suppl. 03) (Suppl): 77-82.
    PubMedGoogle Scholar
  • 2 Scherer PE, Williams S, Fogliano M. et al. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 1995; 270: 26746-26749.
    CrossrefPubMedGoogle Scholar
  • 3 Yamauchi T, Kamon J, Waki H. et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001; 7: 941-946.
    CrossrefPubMedGoogle Scholar
  • 4 Yamauchi T, Kamon J, Minokoshi Y. et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 2002; 8: 1288-1295.
    CrossrefPubMedGoogle Scholar
  • 5 Kadowaki T, Yamauchi T. Adiponectin and adiponectin receptors. Endocr Rev 2005; 26: 439-451.
    CrossrefPubMedGoogle Scholar
  • 6 Vionnet N, Hani El H, Dupont S. et al. Genomewide search for type 2 diabetes-susceptibility genes in French whites: evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome 1q21-q24. Am J Hum Genet 2000; 67: 1470-1480.
    CrossrefPubMedGoogle Scholar
  • 7 Kissebah AH, Sonnenberg GE, Myklebust J. et al. Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome. Proc Natl Acad Sci USA 2000; 97: 14478-14483.
    CrossrefPubMedGoogle Scholar
  • 8 Francke S, Manraj M, Lacquemant C. et al. A genome- wide scan for coronary heart disease suggests in Indo-Mauritians a susceptibility locus on chromosome 16p13 and replicates linkage with the metabolic syndrome on 3q27. Hum Mol Genet 2001; 10: 2751-2765.
    CrossrefPubMedGoogle Scholar
  • 9 Qi L, Li T, Rimm E. et al. The +276 polymorphism of the APM1 gene, plasma adiponectin concentration, and cardiovascular risk in diabetic men. Diabetes 2005; 54: 1607-1610.
    CrossrefPubMedGoogle Scholar
  • 10 Vasseur F, Helbecque N, Lobbens S. et al. Hypoadiponectinaemia and high risk of type 2 diabetes are associated with adiponectin-encoding (ACDC) gene promoter variants in morbid obesity: evidence for a role of ACDC in diabesity. Diabetologia 2005; 48: 892-899.
    CrossrefPubMedGoogle Scholar
  • 11 Stenvinkel P, Marchlewska A, Pecoits-Filho R. et al. Adiponectin in renal disease: relationship to phenotype and genetic variation in the gene encoding adiponectin. Kidney Int 2004; 65: 274-281.
    CrossrefPubMedGoogle Scholar
  • 12 Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998; 15: 539-553.
    CrossrefPubMedGoogle Scholar
  • 13 Chobanian AV, Bakris GL, Black HR. et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. J Am Med Assoc 2003; 289: 2560-2572.
    CrossrefPubMedGoogle Scholar
  • 14 Drexel H, Amann FW, Rentsch K. et al. Relation of the level of high-density lipoprotein subfractions to the presence and extent of coronary artery disease. Am J Cardiol 1992; 70: 436-440.
    CrossrefPubMedGoogle Scholar
  • 15 Drexel H, Amann FW, Beran J. et al. Plasma triglycerides and three lipoprotein cholesterol fractions are independent predictors of the extent of coronary atherosclerosis. Circulation 1994; 90: 2230-2235.
    CrossrefPubMedGoogle Scholar
  • 16 Antman E, Bassand J-P, Klein W. et al. Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarction: The Joint European Society o Cardiology/ American College of Cardiology Committee. J Am Coll Cardiol 2000; 36: 959-969.
    CrossrefPubMedGoogle Scholar
  • 17 Risch L, Hoefle G, Saely C. et al. Evaluation of two fully automated novel enzyme-linked immunosorbent assays for the determination of human adiponectin in serum. Clin Chim Acta 2006; 373: 121-126.
    CrossrefPubMedGoogle Scholar
  • 18 Lewontin RC. On measures of gametic disequilibrium. Genetics 1988; 120: 849-852.
    PubMedGoogle Scholar
  • 19 Xie X, Ott J. Testing linkage disequilibrium between a disease gene and marker loci. Am J Hum Genet 1993; 53: 1107 (abstract)
    PubMedGoogle Scholar
  • 20 Terwilliger JO. Handbook of Human Genetic Linkage. Baltimore: John Hopkins University Press; 1994
    Google Scholar
  • 21 Lacquemant C, Froguel P, Lobbens S. et al. The adiponectin gene SNP+45 is associated with coronary artery disease in Type 2 (non-insulin-dependent) diabetes mellitus. Diabet Med 2004; 21: 776-781.
    CrossrefPubMedGoogle Scholar
  • 22 Vasseur F, Helbecque N, Dina C. et al. Single-nucleotide polymorphism haplotypes in the both proximal promoter and exon 3 of the APM1 gene modulate adipocyte-secreted adiponectin hormone levels and contribute to the genetic risk for type 2 diabetes in French Caucasians. Hum Mol Genet 2002; 11: 2607-2614.
    CrossrefPubMedGoogle Scholar
  • 23 Kumada M, Kihara S, Sumitsuji S. et al. Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 2003; 23: 85-89.
    CrossrefPubMedGoogle Scholar
  • 24 Sattar N, Wannamethee G, Sarwar N. et al. Adiponectin and coronary heart disease: a prospective study and meta-analysis. Circulation 2006; 114: 623-629.
    CrossrefPubMedGoogle Scholar